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ABSTRACT 
Objective: In this study, the embryonic rat cardiomyocyte cell line H9C2 was used to investigate the cardiotoxicity effect of sappan wood ethanol 
extract (SWEE). 
Methods: Sappan wood was extracted in 96% ethanol and divided into dose concentrations of 2.5, 5, 10, 50, 100, and 150 μg/ml, with deferiprone 
used as a control. Cell viability was assessed using the PrestoBlue Cell Viability Reagent, according to manufacturer protocols.  
Results: Microscopic examination showed that the cell viability of H9C2 was preserved by SWEE treatments at a dose of 10 μg/ml and suggested 
dose concentrations of 50 μg/ml of SWEE. The percentage of viable cells was greater than 95% with a dose concentration of 10 μg/ml of SWEE, but 
it was significantly reduced with a dose concentration of 50 μg/ml of SWEE (p<0.05).  
Conclusion: The optimal dose concentration of SWEE to reach 95% cell viability was 10 μg/ml. 
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Blood transfusion plays an important therapeutic role in patients 
with a history of diseases such as β-thalassemia, anemia, and 
myelodysplastic syndromes (MDS) [1–3]. Blood transfusion therapy 
has the risk of long-term side effects, causing an iron overload, 
where excess iron in the body accumulates in several organs, such as 
the liver, endocrine system, and heart. The heart is one of the main 
sites where excess iron accumulates [1]. The heart is an organ with 
high oxygen consumption, and it is rich in unsaturated fatty acids 
that can produce reactive oxygen species (ROS) [4]. Excessive iron 
accumulation in the heart causes cardiomyopathy, a disease which 
can lead to heart failure [1]. Cardiomyopathy is caused by cell death 
that begins with an increase in oxidative stress that causes 
apoptosis. When iron levels exceed the capacity limit of ferritin, cell 
death and organ damage will occur due to the presence of ROS and 
their consequent mutations [5]. Based on this reaction, it is clear 
that iron chelation is needed to control the amount of iron in the 
body, especially in iron overload conditions.  
Iron chelators are categorized into several types, such as synthetic 
chelators, siderophores, and phytochemical chelators. Iron chelators 
that are widely used in therapy derive from synthetic chelators, for 
example, deferiprone [6]. However, long-term use of deferiprone can 
cause side effects. Iron chelator agents were revealed to be 
ineffective and toxic in most patients and have side effects such as 
diabetes mellitus (DM) in non-DM patients [7]. At this time, much 
research has focused on phytochemical chelators, such as sappan 
wood (Caesalpinia sappan L.). Sappan wood is a good candidate for 
iron chelation because it contains high flavonoid compounds and 
brazilin. Our previous studies showed that flavonoid and brazilin 
could decrease the ferritin level and increase transferrin with almost 
the same results as deferiprone, an iron-chelating agent, as a control. 
The decrease in ferritin indicated that sappan wood extract has the 
ability to chelate the iron. Research has tested the use of sappan 
wood ethanol extract (SWEE) as an iron chelator in vivo using rats, 
where SWEE reduced iron in the blood and improved the function of 
rat livers with excessive iron accumulation [8–10]. However, further 
investigation is necessary to investigate the toxicity of SWEE in the 
target organ. In this study, we tested the viability of SWEE in vitro 
using the H9C2 rat cardiomyocytes cell line. 
MATERIALS AND METHODS 
Preparation of SWEE 
Sappan wood was dried in the open air and extracted with a 96% 
ethanol solvent using the maceration method. The maceration was 
concentrated on a rotary evaporator at 40˚C [10]. The dried extract 
of Sappan wood was dissolved in dimethyl sulfoxide (DMSO) for 
further testing. 
Cell cultures and treatment 
The H9C2 cell line was obtained from Central Laboratory in our 
university and the test was carried out from July to August 2019. The cell 
culture and treatment was modelled after Hanif et al. (2019). The H9C2 
cell line was plated in a Roswell Park Memorial Institute (RPMI) medium 
with 10% Fetal Bovine Serum (FBS) and with antibiotics at 50 µl/50 ml 
on 96 well plates [12]. After reaching confluence, cells were treated with 
SWEE in different concentrations, i.e. 150, 100, 50, 10, 5, 2.5 µg/ml. 
Deferiprone was used as a positive control in various concentrations, i.e. 
100 mmol, 10 mmol, 1 mmol, 100 µM, 10 µM, 1 µM. Cells were incubated 
at 37˚C for 24 h in an incubator with 5% CO2 levels.  
Prestoblue cell viability assay 
Cell viability was measured using the PrestoBlue Cell Viability assay. 
PrestoBlue reagents were added to the media at a ratio of 9:1. The 
mixture of reagents and media (100 µl) was added to treatment cells 
and incubated at 37 C for 2 h. Absorption was measured for cell 
viability with a wavelength of 570 nm (reference: 600 nm) using a 
multi-mode plate reader. 
Microscopy examination 
Microscopic examination of H9C2 cardiomyocytes was performed by 
using EVOS XL CORE microscope with magnification 20×.  
Statistical analysis 
Data were analyzed using GraphPad Prism. One-way analysis of 
variance (ANOVA) was conducted for three samples, and the Tukey 
post-hoc multiple comparison test was performed to evaluate 
differences. A p-value of<0.05 was considered statistically 
significant. 
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RESULTS 
Cytotoxic activity of SWEE on the H9C2 cell line
A cytotoxic examination of SWEE with concentrated variants of the 
H9C2 cell line showed a change of color after
reagent was applied: the cell line turned purple 
several wells (fig. 1). The pink color indicated 
 
Fig. 1: Presto
Deferiprone was used as a positive control because 
used in therapy to reduce iron overload condition
with blood disorders who need long-term
(thalassemia mostly). The results showed that well colour shifted 
to purple only at a concentration of 100 mM of deferiprone
 
Fig. 2: Effects of deferiprone (A) and SWEE (B) Toxicity on H9C2 
Fig. 3: The morphological appearance of the H9C2 
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Microscopic examination of cellular morphology 
Microscopic examination was used to assess cellular morphology. 
Treating the H9C2 cell line with SWEE for 24 h showed signs of 
morphological toxicity. Microscopic examination results showed 
that cell damage began at a concentration of 50 µg/ml to 150 
µg/ml of SWEE, which was marked by membrane blebbing, loss of 
original cell shape to loss of cell viability, and the formation of cell 
debris, as shown in fig. 3. Results from this microscopic 
examination supported the results of the multi-mode plate reader 
and PrestoBlue Cell Viability assays, which showed signs of cell 
death and decreased cell viability at concentrations of 50 µg/ml to 
150 µg/ml. Different results were obtained when SWEE 
concentrations of 2.5 μg/ml to 10 μg/ml were added to cells, 
showing no signs of cell death. In these cases, cell viability also 
remained above 95%. When compared with the deferiprone as 
control, the signs of toxicity appeared in several cells at a dose of 
100 mM (fig. 3). 
DISCUSSION 
In vitro experiments using the H9C2 cell lines were used to 
investigate the effects of SWEE on cardiomyocytes. SWEE had toxic 
effects at doses above 50 µg/ml, along with significantly decreased 
cell viability. Previous SWEE in vivo toxicity tests using Wistar rats 
showed no toxic effects or allergic reactions, and no rats died until 
the SWEE dose reached 5000 mg/kg [11]. Furthermore, SWEE 
toxicity testing was also carried out in vitro on several cancer cells to 
test their toxicity on the cancer cells themselves, for example, in 
breast, cervical, and colon cancer cells [12, 13]. In contrast with 
these previous studies, our study used the H9C2 rat cardiomyocytes 
cell line because we wanted to test the toxicity of SWEE in normal 
cells, including cardiomyocytes. 
Blood transfusions can cause excess iron in the body [14]. The 
excess iron in the body then accumulates in several organs, one of 
which is the heart [1–3]. Excess iron in cells can increase reactive 
oxygen species (ROS) and result in ferroptosis. Increasing ROS can 
induce decreasing of glutathione peroxidase 4 (GPx4), so that can 
induce lipid peroxidation until ferroptosis occurred [15]. Excess cell 
death in the heart can cause heart failure. Heart failure is the final 
stage of cardiovascular disease, characterized by a loss of myocytes 
due to cell death [16]. 
Sappan wood is a plant that has high flavonoid content and contains 
five antioxidant compounds, including brazilin. Flavonoids and 
brazilin make Sappan wood a good candidate as an iron-chelating 
agent. Based on in vivo testing, SWEE was able to reduce iron in the 
blood and improve the function of rat livers with excessive iron [8–
10]. This study performed a cell viability test using SWEE, but 
further testing is needed to determine the ability of SWEE to act as 
an iron chelator in vitro. The morphology of cell death from the 
H9C2 cell line shows the characteristics of cell death through 
apoptosis. The characteristics of apoptosis are marked by the 
presence of chromosome condensation, in contrast to necrosis and 
autophagy, which possess the characteristics of a destroyed plasma 
membrane (necrosis) and double-layered membrane vacuole 
(autophagy) [15].  
CONCLUSION 
The optimal dose concentration of SWEE to reach 95% cell viability 
is 10 µg/ml. 
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